If he doesn't take it people will say he doesn't trust his product, the science etc.
If he does take it (or he and the exec team do) people will say, see just another rich guy getting his before the regular people do, taking advantage of the system. Or people will point to it as some sort of white privilege.
I think he should've taken it and accepted the "privilege" criticism to show confidence in his product, but I recognize he was going to get slammed either way.